Introduction
It is known that cancer is one of the most dangerous diseases, caused by uncontrolled growth and spread of abnormal cells, initiated by viruses, smoking, chemicals, or diet.
1 Cancer can lead to death if left untreated.
Therefore, many of the research efforts aim to develop new anticancer drugs.
2−6
The 1,2,4-triazolopyrimidines have attracted growing interest due to their important pharmacological activities, such as antitumor potency, 7−12 antimalarial, 13 antimicrobial, 14−17 anti-inflammatory, 18 inhibition of kinase insert domain containing receptor (KDR kinase), 19 antifungal, 20 and macrophage activation. 21 In addition, triazolo [4,3-a] pyrimidine derivatives were reported to be useful as antihypertensive, 22 anxiolytic, 23 and cardiovascular 24, 25 agents.
In view of these reports and in continuation of our previous work on the synthesis of bioactive heterocyclic compounds, 26−32 we were interested in the synthesis of new fused triazolopyridinones to investigate their antimicrobial and cytotoxic potential activities. * Correspondence: s.m.gomha@hotmail.com
Results and discussion

Chemistry
The starting compound 7,9-bis(4-methoxyphenyl)-2-thioxo-2,3-dihydropyrido [3',2':4,5] thieno [3,2-d ] pyrimidin-4(1H)-one (3) was prepared by adopting a reported procedure 33 as depicted in Scheme 1. Thus, the reaction of 4,6-di(4-methoxyphenyl)-2-thioxo-1,2-dihydropyridine-3-carbonitrile (1) 34 with chloroacetamide in refluxed ethanol containing KOH afforded compound 2. The structure of compound 2 was confirmed on the basis of its spectral data (see Experimental). Treatment of the latter compound with CS 2 in pyridine followed by acidification led to the formation of the starting material 3. The structure of 3 was evidenced by its spectral data (mass, IR, 1 H NMR) and thermal analysis. Its IR spectrum revealed the absorption bands of two -NH and CO in the regions 3459, 3359, and 1691 cm −1 , respectively while its 1 H NMR spectrum showed two characteristic signals at δ = 9.29 and 12.99 ppm (D 2 O exchangeable) assignable to two -NH protons.
Scheme 1. Synthesis of thione 3 and its methylthio derivative 4.
The methylthio derivative 4 was prepared from the reaction of thione 3 with methyl iodide in the presence of anhydrous K 2 CO 3 . The 1 H NMR spectrum of compound 4 showed the signals of S-CH 3 and NH at δ = 3.56 and 12.96 ppm, respectively.
Reaction of 3 with each of 5a-l was carried out in dioxane, in the presence of triethylamine, under reflux until hydrogen sulfide ceased to evolve, affording, in each case, one isolable product as evidenced by TLC analysis (Scheme 2). The isolated products were assigned the structure of pyridothieno [3,2-d] triazolo-pyrimidin-5(1H)-ones 8a-l rather than its isomeric structure pyridothieno [2,3- e]triazolo-pyrimidin-5(3H)-one 10 based on their elemental analyses and IR, 1 H NMR, and 13 C NMR spectra (see Experimental). For example, the δ values (δ = 164 ppm) for the carbonyl carbon signal in the 13 C NMR spectra of 8a are similar to those of compounds of type A (δ = 161-164 ppm) and different from those of their isomers having structure B (δ = 170-175 ppm) 35 ( Figure 1 ). This finding excludes structure 10 for the products. Compound 8 was further evidenced by alternate synthesis, via refluxing 2-methylthio derivative 4 with 5a-l in the presence of triethylamine until the evolution of methanethiol ceased and products formed that proved identical in all respects (IR, MS, mp, and mixed mp) with 8a-l. The assumption that the latter reaction proceeds through the amidrazone intermediate 9 is compatible with the literature. 36 
13
Figure 1.
13 C NMR shifts of strategic carbon atoms.
Formation of compounds 8 could be started with the formation of thiohydrazonate esters 6 from hydrazonoylation of thione 3, followed by Smiles rearrangement 37 to form the respective thiohydrazides 7.
Cyclization of 7 followed by removal of H 2 S yielded 8 (Scheme 2). Alternatively, the formation of 8 from methylthio derivative 4 and hydrazonoyl halides 5 can be accomplished via cyclization of the amidrazone 9 (Scheme 2).
The involvement of 6 and 7 as intermediates in the formation of 8 was evidenced by alternate synthesis of 8b, f, and j (Scheme 2). Thus, treatment of 3 with each of the active chloromethylene compounds 11a-c in KOH/ DMF at room temperature yielded the substitution products 12a-c (Scheme 3). The structure of the latter products was elucidated by its microanalysis and spectral data (mass, IR, 1 H NMR). The 1 H NMR data showed singlet signals at δ = 2.34 and 4.01 ppm assignable to the methyl and methine protons, respectively, in addition to the characteristic signals corresponding to COMe, COOEt, and CONHPh groups in the compounds 12a-c, respectively. The formation of 12a-c from the reaction of 3 with 11a-c (Scheme 3) is analogous to S-alkylation reactions reported for 2-thioxopyrimidines.
38
Coupling of 12a-c with benzenediazonium chloride yielded the corresponding thiohydrazonate esters 6b, f, and j, which undergo in situ Smiles rearrangement to give the intermediates 7b, f, and j, which could be cyclized into the corresponding 8b, f, and j. This finding indicates that 6 and 7 are intermediates in the studied reactions of 3 with 5a-l.
Finally, the suggestion that the site of cyclization of the thiohydrazide intermediates 7 involves N-3 to give 8 is consistent with literature reports.
39−41
2-Hydrazinyl-7,9-di(4-methoxyphenyl)pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(3H)-one (13) was prepared by refluxing compound 4 with NH 2 NH 2 .H 2 O in DMF. Condensation of compound 13 with different aldehydes 14a-f in acetic acid gave the corresponding hydrazone derivatives 15a-f (Scheme 4). The mass spectra of the isolated products 15a-f showed the molecular ion peaks at the expected m/z values. Their IR spectra showed the disappearance of the NH 2 group, and revealed in each case a carbonyl band in the region 1651-1670 cm −1 and two bands at 3444-3448 and 3348-3363 cm −1 assignable to two -NH groups. Furthermore, the 1 H NMR spectra showed, in each case, the presence of the azomethine and two -NH protons at δ = 8.11-8.20, 10.98-11.16, and 11.69-11.89 ppm, respectively.
Oxidative cyclization of the hydrazone derivatives 15a-f with bromine in acetic acid in the presence of sodium acetate at room temperature yielded in each case one isolable product 16a-f (Scheme 4). The products 16a-f were deduced from their spectral data (IR, 1 H NMR, and ESI-MS) and elemental analyses, which are listed in the Experimental part. In addition, compound 16a was synthesized by an alternative method via reaction of compound 13 with benzoyl chloride in pyridine.
Biological activity
Antimicrobial evaluation
The newly synthesized target compounds were evaluated for their in vitro antibacterial activity against two gram-positive bacterial species (Bacillus subtilis and Staphylococcus aureus), two gram-negative bacterial species (Escherichia coli and Pseudomonas aeruginosa), two moulds (Aspergillus fumigatus and Syncephalastrum racemosum), and two yeasts (Candida albicans and Geotrichum candidum) using a modified well diffusion
method. The organisms were tested against the activity of solutions of concentrations (5 mg/mL) and using inhibition zone diameter in millimeters as criterion for the antimicrobial activity (agar well diffusion method). The results of testing for antibacterial and antifungal effects are summarized in Tables 1 and 2 . As shown by these results, the new fused triazolopyrimidinone derivatives tested displayed variable in vitro antibacterial and antifungal actions. In general, the chemical structure of the whole molecule, comprising the nature of the heterocyclic system as well as the type of the substituted function present in the heterocyclic ring structure, has a pronounced effect on antimicrobial activity. Most of the corresponding substituted analogues produced higher inhibitory effects against bacteria similar or superior to the reference drug tetracycline.
From the screening results, it can be seen that compounds 8f and 15f showed the highest activity against gram-positive bacteria and compound 15d showed the highest activity against gram-negative bacteria. The rest of the compounds showed good to moderate activity against the tested bacteria compared with the standard drugs. Interestingly, compound 15b showed higher inhibitory activity against Aspergillus fumigates compared with amphotericin B reference drug. Despite promising in vitro antifungal activity of some of the newly synthesized compounds, only compounds 8d, 8e, 8c, 8l, and 8j among the compounds tested exhibited high antifungal activity as compared with those of the reference drug against yeast species. Compound 8c also exhibited a higher inhibitory effect than the reference drug, amphotericin B.
The mean values of the inhibition zone diameter obtained for these compounds suggest that all synthesized compounds possess significant antimicrobial activity against most test organisms used in these assays (Tables 1   and 2 ); therefore, minimum inhibitory concentration (MIC) of various synthesized compounds was evaluated in vitro using the two-fold serial dilution technique, while the lowest concentration showed no growth as the MIC. The fungicides amphotericin B and gentamicin as well as the bactericides ampicillin and tetracycline were used as references to evaluate the potency of the tested compounds under the same conditions. The results of MIC are reported in Table 3 . Compound 15d showed an appreciable broad spectrum of action against both gram-positive and gramnegative bacteria with an antibacterial potency higher than that of their reference drug. Compound 15d reached the highest potency with MIC 100 and 50 µ g/mL against S. aureus, E. coli, and P. aureginosa, respectively. Significant MIC values were determined for compounds 8c and 15b against the tested fungi. Based on the biological evaluation, most of the compounds tested, in particular 8c, 8f, 8l, 15b, and 15f, may be considered new antimicrobial agents.
Cytotoxic activity
The in vitro growth inhibitory activity of the synthesized compounds was investigated in comparison with 5-fluorouracil, doxorubicin, and imatinib 42 as standard drugs. The data generated were used to plot a dose response curve of which the concentration of test compounds required to kill 50% of the cell population (IC 50 ) was determined and the results revealed that all the tested compounds showed inhibitory activity to the tumor 125  100  50  50  200  250  250  250  15e  500  250  500  500  ----15f  100  100  200  250  500  500  500  500  Tetracycline  50  50  50  50  ----Ampicillin  100  250  100  100  ----Griseofulvin  ----100  250  250  200  Amphotericin B ----50  100  100  100 cell lines in a concentration dependent manner. Cytotoxic activity was expressed as the mean IC 50 of six replicates in three independent experiments. The results are represented in Table 4 and Figures 2-4 show that compounds 12a, 12b, and 12c have the highest cytotoxic activity against the two tumor cell lines MCF-7 and HepG-2, compared with reference drugs; thus these compounds were evaluated for their inhibitory effect on HCT-116 and HeLa cell lines. Moreover, compound 12c was the most active against MCF-7, HepG-2, HCT-116, and HeLa with IC 50 values of 0.51, 0.72, 0.95, and 0.95, respectively, as compared with doxorubicin. Interestingly, compounds 12a, 12b, 12c, 15a, and 15c exhibited 48-to 1.07-fold more potent antitumor activity than imatinib against breast carcinoma (MCF-7) cell lines and were the most active among their analogues. Furthermore, compounds 15a, 8f, and 15c showed cytotoxic effects against HepG2 comparable to imatinib. Moreover, compounds 8a, 8b, 8c, 8d, 8e, 8g, 8h, 8i, 8j, 8k, 15b, 15d, and 15e were less active than imatinib.
In light of the results presented in this work and taking into account that this preliminary study did not produce conclusive evidence regarding a structure antimicrobial activity relationship, we focused our attention on the most promising compounds, 8c, 8f, 8d, and 15d, as an interesting starting point for the development of a new class of antimicrobial agents. However, compounds 12c, 12a, and 12b exhibited promising inhibitory activity against the four tested tumor cells. We think that research in this direction should be encouraged in order to broaden the applicability of these new heterocyclic frameworks to serve as leads for designing novel chemotherapeutic agents. 
Experimental
Chemistry
Melting points were recorded on Gallenkamp electrothermal apparatus.
H NMR was determined on a Varian
Gemini 300 spectrometer (300 MHz) in DMSO-d 6 with TMS as internal standard. Elemental analyses were carried out at the Microanalytical Center, University of Cairo, Giza, Egypt. Mass spectra were recorded on a GCMS-QP 1000 EX Shimadzu spectrometer. Infrared spectra (KBr) were determined on a Pye Unicam SP-3000 infrared spectrophotometer. Hydrazonoyl halides 5 43−46 were prepared according to literature procedures.
Synthesis of 3-amino-4,6-di(4-methoxyphenyl)thieno[2,3-b]pyridine-2-carboxamide (2).
A mixture of 2-mercapto-4,6-di(4-methoxyphenyl)nicotinonitrile 1 (3.84 g, 10 mmol) and potassium hydroxide (0.56 g, 10 mmol) in ethanol (20 mL) was refluxed for 8 h under reflux. Method A: General procedure: triethylamine (1.4 mL, 10 mmol) was added to a mixture of equimolar amounts of thione 3 (0.447 g, 1 mmol) and the appropriate hydrazonoyl halides 5a-l (10 mmol) in 50 mL of dioxane. The reaction mixture was refluxed until all of the starting materials disappeared and hydrogen sulfide gas ceased to evolve (6-10 h, monitored by TLC). The solvent was evaporated and the solid that formed was filtered and recrystallized from the appropriate solvent to give compounds 8a-l, respectively.
Method B:
When the above procedure was repeated using methylthio derivative 4 (0.461 g, 1 mmol) in lieu of 3, the product proved to be identical in all respects with 8a-l prepared above. The physical constants of compounds 8a-l are listed below. 
3-Acetyl-1-(4-chlorophenyl)-8,10-di(4-methoxyphenyl)pyrido[3',2':4,5]thieno[3,2-d][1,2,4] triazolo[4,3-a]pyrimidin-5(1H )-one (8d
Synthesis of 12a-c
General procedure: 1 mL of an aqueous solution of KOH (75%) was added to 4.47 g of 3 (10 mmol) in 50 mL of ethanol and the mixture was warmed for 10 min. The appropriate chloromethylene compound 11a-c (10 mmol) was added to the resulting clear solution and then the reaction mixture was stirred for 12 h at room temperature. The solid that precipitated was filtered off, washed with water, dried, and crystallized from the appropriate solvent to give 12a-c, respectively. 
3-((7,9-Di(4-methoxyphenyl)-4-oxo-3,4-dihydropyrido[3',2':4,5]thieno[3,2-d]pyrimidin-2-yl) thio)pentane-2,4-dione (12a
Alternate synthesis of 8b, 8f, and 8j
A cold solution of benzenediazonium chloride, prepared by diazotizing aniline (1 mmol) dissolved in hydrochloric acid (6 M, 1 mL) with a solution of sodium nitrite (0.07 g, 1 mmol) in water (2 mL) was added portion-wise to a solution of the appropriate 12a-c (1 mmol) in ethanol (20 mL) containing sodium acetate trihydrate (0.138 g, 1 mmol) while stirring and keeping the temperature below 5
• C. The reaction mixture was left for 3 h in a refrigerator. The solid precipitated was filtered off, washed with water, dried, and crystallized from DMF to give compounds 8b, 8f, and 8j, which were identical in all respects (mp, mixed mp, and IR spectra) with those obtained from reaction of 3 with 5b, 5f, and 5j, respectively.
Synthesis of 2-hydrazinyl-7,9-di(4-methoxyphenyl)pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-
4(3H )-one (13).
Hydrazine hydrate (80%, 20 mL) was added to 7,9-di(4-methoxyphenyl)-2-(methylthio)pyrido 
Synthesis of hydrazones 15a-f
A mixture of hydrazine 13 (0.89 g, 2 mmol) and the appropriate aldehyde 14a-f (2 mmol) in acetic acid (20 mL) and a few drops of conc. hydrochloric acid (≈ 1 mL) was heated under reflux for 5 h. The reaction mixture was then cooled and diluted with water. The so-formed solid product was then collected by filtration, dried, and recrystallized from DMF to afford the corresponding hydrazones 15a-f. Benzylidenehydrazinyl)-7,9-di(4-methoxyphenyl) 
2-(2-
2-(2-(4-Methoxybenzylidene)hydrazinyl)-7,9-bis(4-methoxyphenyl)pyrido[3',2':4,5] thieno [3,2-d]pyrimidin-4(3H )-one (15c
Cyclization of hydrazones 15a-f
Bromine (0.052 g, 1 mmol) in acetic acid (5 mL) was added dropwise to a stirred solution of the appropriate hydrazone 15a-f (1 mmol of each) in acetic acid (10 mL) and sodium acetate (0.5 g). The reaction mixture was then poured onto ice cold water, and the solid that precipitated was filtered off, washed with sodium bicarbonate solution and then with water, dried, and crystallized from DMF to give the respective compounds 16a-f. 
Alternate synthesis of 16a
To a solution of hydrazine 13 (0.445 g, 1 mmol) in dry pyridine (20 mL) was added benzoyl chloride (0.14 g, 1 mmol) and the resulting mixture was refluxed for 2 h. After cooling, the precipitate was collected by filtration and crystallized from DMF to afford a product that was found to be identical in all respects (mp, mixed mp, and IR) with product 16a.
Biological evaluation
Antimicrobial activity assay
All microbial strains were provided from the culture collection of the Regional Center for Mycology and Biotechnology (RCMB), Al-Azhar University, Cairo, Egypt. The preliminary antimicrobial activity was investigated on a dozen newly synthesized compounds in order to increase the selectivity of these derivatives towards test microorganisms. Briefly, 100 µ L of the test bacteria/fungi were grown in 10 mL of fresh media until they reached a count of approximately 10 8 cells/mL for bacteria or 10 5 cells/mL for fungi. 47 Then 100 µ L of microbial suspension was spread onto agar plates corresponding to the broth in which they were maintained and tested for susceptibility by the well diffusion method. The National Committee for Clinical Laboratory Standards (NCCLS) recommends Mueller-Hinton and Sabouraud agar as they result in good batch-to-batch reproducibility. The diffusion method for filamentous fungi and yeast was tested by using the approved standard methods (M38-A and M44-P, respectively) developed by the NCCLS 48 for evaluating susceptibilities to antifungal agents.
One hundred microliters of each sample (at 5 mg/mL) was added to each well (10 mm diameter holes cut in the agar gel). The plates were incubated for 24-48 h at 37
• C (for bacteria and yeast) and for 48 h at 28
• C (for filamentous fungi). After incubation, the microorganism's growth was observed. The resulting inhibition zone diameters were measured in millimeters and used as the criterion for antimicrobial activity. If an organism is placed on the agar it will not grow in the area around the well if it is susceptible to the chemical. This area of no growth around the disk is known as a zone of inhibition. The size of the clear zone is proportional to the inhibitory action of the compound under investigation. Solvent controls (DMSO) were included in every experiment as negative controls. DMSO was used for dissolving the tested compounds and showed no inhibition zones, confirming that it has no influence on growth of the tested microorganisms.
MIC determination using the broth microdilution method
The in vitro antimicrobial activity of the synthesized compounds was screened using the broth dilution method as described by CLSI 49 to determine the lowest concentration inhibiting growth of the organism recorded as the MIC using DMSO as diluent. Mueller-Hinton broth was used as nutrient medium to grow and dilute the drug suspension for the tested bacteria, and Sabouraud dextrose broth was used for fungal nutrition. The stock 1000 µ g/mL was prepared. For the broth microdilution test, 50 µ L of each microbial suspension in suitable growth medium was added to the wells of a sterile 96-well microtiter plate already containing 50 µ L of two-fold serially diluted tested compound. Control wells were prepared with culture medium, microbial suspension only, tested compound only, and DMSO in amounts corresponding to the highest quantity present. The contents of each well were mixed on a microplate shaker at 900 rpm for 1 min prior to incubation for 24-48 h in the cultivation conditions described above. The MIC was the lowest concentration where no viability was observed after 24-48 h on the basis of metabolic activity. To indicate respiratory activity the presence of color was determined after adding 10 µ L/well of 2,3,5-triphenyl tetrazolium chloride dissolved in water (20 mg/mL) and incubation under appropriate cultivation conditions for 30 min in the dark. 50 After incubation, the optical density was measured by a microplate reader. Positive controls were wells with a microbial suspension in an appropriate growth medium in amounts corresponding to the highest quantity present in the broth microdilution assay. Negative controls were wells with growth medium and tested compound. All measurements of MIC values were repeated in triplicate. Tetracycline and ampicillin were used as standard antibacterial drugs, while griseofulvin and amphotericin B were used as standard antifungal drugs.
Evaluation of the antitumor activity using a viability assay
All human anticancer cell lines were obtained from the American Type Culture Collection. The cells were grown on RPMI-1640 medium supplemented with 10% inactivated fetal calf serum and 50 µ g/mL gentamicin. The cells were maintained at 37
• C in a humidified atmosphere with 5% CO 2 and were subcultured two to three times a week. Gangadevi and Muthumary's method 51 was used for evaluation of the potential cytotoxicity of the tested compounds. The number of surviving cells was determined by staining the cells with crystal violet 51, 52 followed by cell lysing using 33% glacial acetic acid and reading the absorbance at 590 nm using a microplate reader (SunRise, TECAN, Inc, USA) after mixing well.
The 50% inhibitory concentration (IC 50 ), the concentration required to cause toxic effects in 50% of intact cells, was estimated from graphic plots.
Conclusion
A novel series of fused [1, 2, 4] triazolo [1,5-a] pyrimidines were synthesized by different methods and evaluated for their in vitro antibacterial, antifungal, and anticancer activities. From the screening results, it can be seen that compounds 8f and 15f showed excellent activity against gram-positive bacteria and compound 15d showed potent activity against gram-negative bacteria. The rest of the compounds showed good or moderate activity against the tested bacteria compared with the standard drugs. Compounds 8d, 8e, 8c, 8l, and 8j among the compounds tested exhibited higher antifungal activity as compared with the reference drug against yeast species. The in vitro cytotoxic activity testing revealed that compounds 12c, 12a, and 12b exhibited promising inhibitory activity against the four tested tumor cells (MCF-7, HepG-2, HCT-116, and HeLa).
